Abstract
AbstractCompounds 1‐((1‐(4‐(2H‐benzo[e][1,3]oxazin‐3(4H)‐yl)phenyl)ethylidene)amino)‐6‐((arylidene)amino)‐4‐(4‐chlorophenyl)‐2‐oxo‐1,2‐dihydropyridine‐3,5‐dicarbonitriles (4a‐j) were prepared, characterized and screened for antimicrobial activity. 3D‐quantitative structure activity relationship (3D‐QSAR) was explained by CoMFA and CoMSIA models to rationalize the antimicrobial activity of the titled compounds. Statistically significant 3D‐QSAR (CoMFA and CoMSIA) models were created which could provide valuable information about the structural modification desired to improvise the biological activity. Additionally, the predictions based on the molecular docking study, against microbial DNA gyrase, were carried out.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
